{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T19:39:35Z","timestamp":1773517175371,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"MH CZ - DRO","award":["UHHK, 00179906"],"award-info":[{"award-number":["UHHK, 00179906"]}]},{"DOI":"10.13039\/501100009553","name":"Czech Health Research Council","doi-asserted-by":"crossref","award":["NU21J-02-00021"],"award-info":[{"award-number":["NU21J-02-00021"]}],"id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"crossref","award":["SVV 260 549"],"award-info":[{"award-number":["SVV 260 549"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00210-024-03740-1","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T08:54:28Z","timestamp":1735894468000},"page":"7343-7352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Coagulation in familial hypercholesterolemic patients: effect of current hypolipidemic treatment and anticoagulants"],"prefix":"10.1007","volume":"398","author":[{"given":"Jaka","family":"Fadraersada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal","family":"Alva-Gallegos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Sko\u0159epa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franti\u0161ek","family":"Musil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krist\u00fdna","family":"Mr\u0161tn\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenka","family":"Javorsk\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate\u0159ina","family":"Matou\u0161ov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenka Kujovsk\u00e1","family":"Kr\u010dmov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark\u00e9ta","family":"Pacl\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Carazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Bl\u00e1ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladim\u00edr","family":"Blaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u0159emysl","family":"Mlad\u011bnka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"key":"3740_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12149","author":"T Baglin","year":"2013","unstructured":"Baglin T, Hillarp A, Tripodi A et al (2013) Measuring Oral Direct Inhibitors (ODIs) of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. https:\/\/doi.org\/10.1111\/jth.12149","journal-title":"J Thromb Haemost"},{"key":"3740_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092542","author":"M Basiak","year":"2022","unstructured":"Basiak M, Hachula M, Kosowski M et al (2022) Effect of PCSK9 inhibitors on hemostasis in patients with isolated hypercholesterolemia. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11092542","journal-title":"J Clin Med"},{"key":"3740_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosissup.2017.05.002","author":"V Blaha","year":"2017","unstructured":"Blaha V, Blaha M, Solichova D et al (2017) Antioxidant defense system in familial hypercholesterolemia and the effects of lipoprotein apheresis. Atheroscler Suppl. https:\/\/doi.org\/10.1016\/j.atherosclerosissup.2017.05.002","journal-title":"Atheroscler Suppl"},{"key":"3740_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2005.09.001","author":"H Borberg","year":"2006","unstructured":"Borberg H, Tauchert M (2006) Rheohaemapheresis of ophthalmological diseases and diseases of the microcirculation. Transfus Apher Sci. https:\/\/doi.org\/10.1016\/j.transci.2005.09.001","journal-title":"Transfus Apher Sci"},{"key":"3740_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/science.3513311","author":"MS Brown","year":"1986","unstructured":"Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Sci. https:\/\/doi.org\/10.1126\/science.3513311","journal-title":"Sci"},{"key":"3740_CR6","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1756703","author":"A Carazo","year":"2023","unstructured":"Carazo A, Hrubsa M, Konecny L et al (2023) Sex-related differences in platelet aggregation: a literature review supplemented with local data from a group of generally healthy individuals. Semin Thromb Hemost. https:\/\/doi.org\/10.1055\/s-0042-1756703","journal-title":"Semin Thromb Hemost"},{"key":"3740_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosissup.2016.10.001","author":"AJ Vallejo-Vaz","year":"2016","unstructured":"Collaboration EASFHS, Vallejo-Vaz AJ, Akram A et al (2016) Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration. Atheroscler Suppl. https:\/\/doi.org\/10.1016\/j.atherosclerosissup.2016.10.001","journal-title":"Atheroscler Suppl"},{"key":"3740_CR8","doi-asserted-by":"publisher","unstructured":"Cuchel M, Bruckert E, Ginsberg HN, et al (2014) Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehu274","DOI":"10.1093\/eurheartj\/ehu274"},{"key":"3740_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13912","author":"J Douxfils","year":"2018","unstructured":"Douxfils J, Ageno W, Samama CM et al (2018) Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians. J Thromb Haemost. https:\/\/doi.org\/10.1111\/jth.13912","journal-title":"J Thromb Haemost"},{"key":"3740_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9050445","author":"C Dunois","year":"2021","unstructured":"Dunois C (2021) Laboratory Monitoring of Direct Oral Anticoagulants (DOACs). Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9050445","journal-title":"Biomedicines"},{"key":"3740_CR11","doi-asserted-by":"publisher","DOI":"10.1177\/1470320315575848","author":"M Ekholm","year":"2015","unstructured":"Ekholm M, Kahan T, Jorneskog G et al (2015) Haemostatic and inflammatory alterations in familial hypercholesterolaemia, and the impact of angiotensin II infusion. J Renin Angiotensin Aldosterone Syst. https:\/\/doi.org\/10.1177\/1470320315575848","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"3740_CR12","doi-asserted-by":"publisher","unstructured":"Ference BA, Ginsberg HN, Graham I, et al (2017) Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehx144","DOI":"10.1093\/eurheartj\/ehx144"},{"issue":"1","key":"3740_CR13","first-page":"386","volume":"86","author":"JH Griffin","year":"2001","unstructured":"Griffin JH, Fernandez JA, Deguchi H (2001) Plasma lipoproteins, hemostasis and thrombosis. Thromb Haemost 86(1):386\u2013394","journal-title":"Thromb Haemost"},{"key":"3740_CR14","doi-asserted-by":"publisher","DOI":"10.1042\/bj2160043","author":"DG Hassall","year":"1983","unstructured":"Hassall DG, Owen JS, Bruckdorfer KR (1983) The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin. Biochem J. https:\/\/doi.org\/10.1042\/bj2160043","journal-title":"Biochem J"},{"key":"3740_CR15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-386227","author":"R Huijgen","year":"2011","unstructured":"Huijgen R, Kastelein JJ, Meijers JC (2011) Increased coagulation factor VIII activity in patients with familial hypercholesterolemia. Blood. https:\/\/doi.org\/10.1182\/blood-2011-10-386227","journal-title":"Blood"},{"key":"3740_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosissup.2017.05.034","author":"U Julius","year":"2017","unstructured":"Julius U (2017) History of lipidology and lipoprotein apheresis. Atheroscler Suppl. https:\/\/doi.org\/10.1016\/j.atherosclerosissup.2017.05.034","journal-title":"Atheroscler Suppl"},{"key":"3740_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd5020027","author":"U Julius","year":"2018","unstructured":"Julius U (2018) Current role of lipoprotein apheresis in the treatment of high-risk patients. J Cardiovasc Dev Dis. https:\/\/doi.org\/10.3390\/jcdd5020027","journal-title":"J Cardiovasc Dev Dis"},{"key":"3740_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1993.tb00781.x","author":"W Knisel","year":"1993","unstructured":"Knisel W, Di Nicuolo A, Pfohl M et al (1993) Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic systems. J Intern Med. https:\/\/doi.org\/10.1111\/j.1365-2796.1993.tb00781.x","journal-title":"J Intern Med"},{"key":"3740_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/nu15081842","author":"L Konecny","year":"2023","unstructured":"Konecny L, Hrubsa M, Karlickova J et al (2023) The effect of 4-methylcatechol on platelets in familial hypercholesterolemic patients treated with lipid apheresis and\/or proprotein convertase subtilisin kexin 9 monoclonal antibodies. Nutrients. https:\/\/doi.org\/10.3390\/nu15081842","journal-title":"Nutrients"},{"key":"3740_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2011.06.027","author":"L Krcmova","year":"2011","unstructured":"Krcmova L, Solichova D, Melichar B et al (2011) Determination of neopterin, kynurenine, tryptophan and creatinine in human serum by high throuput HPLC. Talanta. https:\/\/doi.org\/10.1016\/j.talanta.2011.06.027","journal-title":"Talanta"},{"key":"3740_CR21","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363170-00005","author":"R Krysiak","year":"2003","unstructured":"Krysiak R, Okopien B, Herman Z (2003) Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes. Drugs. https:\/\/doi.org\/10.2165\/00003495-200363170-00005","journal-title":"Drugs"},{"key":"3740_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2013.03.002","author":"MP McGowan","year":"2013","unstructured":"McGowan MP (2013) Emerging low-density lipoprotein (LDL) therapies: management of severely elevated LDL cholesterol\u2013the role of LDL-apheresis. J Clin Lipidol. https:\/\/doi.org\/10.1016\/j.jacl.2013.03.002","journal-title":"J Clin Lipidol"},{"key":"3740_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/nutrit\/nuab061","author":"P Mladenka","year":"2022","unstructured":"Mladenka P, Macakova K, KujovskaKrcmova L et al (2022) Vitamin K - sources, physiological role, kinetics, deficiency, detection, therapeutic use, and toxicity. Nutr Rev. https:\/\/doi.org\/10.1093\/nutrit\/nuab061","journal-title":"Nutr Rev"},{"key":"3740_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2023.464548","author":"K Mrstna","year":"2023","unstructured":"Mrstna K, Matousova K, Krcmova LK et al (2023) Analysis of vitamin K(1) and major K(2) variants in rat\/human serum and lipoprotein fractions by a rapid, simple, and sensitive UHPLC-MS\/MS method. J Chromatogr A. https:\/\/doi.org\/10.1016\/j.chroma.2023.464548","journal-title":"J Chromatogr A"},{"key":"3740_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2023.102152","author":"P Perswani","year":"2023","unstructured":"Perswani P, Ismail SM, Mumtaz H et al (2023) Rethinking HDL-C: an in-depth narrative review of its role in cardiovascular health. Curr Probl Cardiol. https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.102152","journal-title":"Curr Probl Cardiol"},{"key":"3740_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12030226","author":"M Puccini","year":"2022","unstructured":"Puccini M, Landmesser U, Rauch U (2022) Pleiotropic effects of PCSK9: focus on thrombosis and haemostasis. Metabolites. https:\/\/doi.org\/10.3390\/metabo12030226","journal-title":"Metabolites"},{"key":"3740_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.06.859","author":"FJ Raal","year":"2018","unstructured":"Raal FJ, Hovingh GK, Catapano AL (2018) Familial hypercholesterolemia treatments: guidelines and new therapies. Atherosclerosis. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.06.859","journal-title":"Atherosclerosis"},{"key":"3740_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169146","author":"U Ravnskov","year":"2022","unstructured":"Ravnskov U, de Lorgeril M, Kendrick M et al (2022) Importance of coagulation factors as critical components of premature cardiovascular disease in familial hypercholesterolemia. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23169146","journal-title":"Int J Mol Sci"},{"key":"3740_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.53.3.265","author":"DD Sugrue","year":"1985","unstructured":"Sugrue DD, Trayner I, Thompson GR et al (1985) Coronary artery disease and haemostatic variables in heterozygous familial hypercholesterolaemia. Br Heart J. https:\/\/doi.org\/10.1136\/hrt.53.3.265","journal-title":"Br Heart J"},{"key":"3740_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58111665","author":"K Zubieliene","year":"2022","unstructured":"Zubieliene K, Valteryte G, Jonaitiene N et al (2022) Familial hypercholesterolemia and its current diagnostics and treatment possibilities: a literature analysis. Medicina. https:\/\/doi.org\/10.3390\/medicina58111665","journal-title":"Medicina"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03740-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03740-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03740-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T10:47:50Z","timestamp":1748602070000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03740-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3740"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03740-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]},"assertion":[{"value":"3 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the University Hospital Hradec Kr\u00e1lov\u00e9 (no. 202007 S01P from June 18, 2020). All experiments conformed to the latest declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}